MetaCap

Perspective Therapeutics Insider Trades

NYSE: CATXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.7538-0.0302 (-3.85%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
10 · $175.39K
Sales
7 · $1.62M
Shares bought / sold
206.65K / 517.89K
Net activity
Net selling $1.4 million

Perspective Therapeutics insider activity

Over the last 12 months, Perspective Therapeutics insiders reported 17 transactions on SEC Form 4: 10 open-market purchases and 7 sales. Insiders bought $175,386 and sold $1.6 million worth of stock, for net insider selling of $1.4 million. The largest seller was Lantheus Alpha Therapy, LLC & Lantheus Holdings, Inc., with $908,166 in reported sales.

The most recent filing shows Williamson Robert F III (Director) buying 15,000 shares at $0.80 on Nov 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CATX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CATX insider transactions

Perspective Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Nov 18, 2026Williamson Robert F IIIDirectorBuy15,000$12.00KForm 4
Nov 17, 2026Williamson Robert F IIIDirectorBuy25,000$20.95KForm 4
Nov 16, 2026Morich FrankDirectorBuy15,000$14.05KForm 4
Nov 12, 2026Puhlmann MarkusChief Medical OfficerBuy35,000$29.56KForm 4
Nov 12, 2026Woods Lori ADirectorBuy23,750$20.04KForm 4
Nov 12, 2026Williamson Robert F IIIDirectorBuy6,289$5.27KForm 4
Nov 12, 2026Williamson Robert F IIIDirectorBuy18,609$15.63KForm 4
Nov 12, 2026Morich FrankDirectorBuy15,000$14.96KForm 4
Nov 11, 2026Spoor Johan M.Chief Executive OfficerBuy47,000$37.94KForm 4
Nov 11, 2026Puhlmann MarkusChief Medical OfficerBuy6,000$4.98KForm 4
Sep 4, 2026Lantheus Alpha Therapy, LLC & Lantheus Holdings, Inc.10% OwnerSale167,149$526.05KForm 4
Sep 3, 2026Lantheus Alpha Therapy, LLC & Lantheus Holdings, Inc.10% OwnerSale80,783$250.90KForm 4
Sep 2, 2026Lantheus Alpha Therapy, LLC & Lantheus Holdings, Inc.10% OwnerSale42,129$131.22KForm 4
Sep 1, 2026Lantheus Holdings, Inc.10% OwnerSale35,769$111.57KForm 4
Sep 1, 2026Lantheus Alpha Therapy, LLC10% OwnerSale35,769$111.57KForm 4
Aug 31, 2026Lantheus Holdings, Inc.10% OwnerSale78,145$245.61KForm 4
Aug 31, 2026Lantheus Alpha Therapy, LLC10% OwnerSale78,145$245.61KForm 4
Nov 13, 2025Hunt Jonathan RobertChief Accounting OfficerBuy11,000$22.29KForm 4
Nov 12, 2025Williamson Robert F IIIDirectorBuy9,498$19.95KForm 4
Mar 31, 2025Williamson Robert F IIIDirectorBuy38,145$81.78KForm 4
Mar 31, 2025Woods Lori ADirectorBuy23,475$50.00KForm 4
Mar 28, 2025Williamson Robert F IIIDirectorBuy22,192$50.38KForm 4
Mar 28, 2025Spoor Johan M.Chief Executive OfficerBuy4,650$10.29KForm 4
Mar 28, 2025Spoor Johan M.Chief Executive OfficerBuy22,026$49.38KForm 4
Mar 28, 2025Graham JuanChief Financial OfficerBuy33,333$74.95KForm 4
Dec 4, 2024Spoor Johan M.CEOBuy8,000$30.13KForm 4
Dec 4, 2024HENSON HEIDIDirectorBuy25,975$100.00KForm 4
Nov 25, 2024Spoor Johan M.CEOBuy6,600$25.08KForm 4
Nov 25, 2024Spoor Johan M.CEOBuy5,400$20.52KForm 4
Nov 25, 2024Spoor Johan M.CEOBuy14,500$54.87KForm 4
Nov 25, 2024Hunt Jonathan RobertChief Financial OfficerBuy10,000$38.80KForm 4
Nov 25, 2024Hunt Jonathan RobertChief Financial OfficerBuy2,400$8.64KForm 4
Nov 25, 2024Hunt Jonathan RobertChief Financial OfficerBuy29$114.26Form 4
Nov 25, 2024Hunt Jonathan RobertChief Financial OfficerBuy400$1.42KForm 4
Nov 25, 2024Williamson Robert F IIIDirectorBuy2,619$9.61KForm 4
Nov 25, 2024Williamson Robert F IIIDirectorBuy3,647$13.20KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related